Sustainability & Climate

Brazilian importers bypass high local credit costs using a Chinese state-backed insurance, unlocking cash flow and fueling a new wave of trade growth.

A single-dose therapy wiped out aggressive glioblastoma tumors in a landmark pre-clinical study, paving the way for human trials in 2026.

Ex-Global X exec Rob Oliver launches Aura ETFs. Its first fund, DUTY, taps into defense spending and donates 10% of fees to military veteran charities.

With most OUD patients lacking access to care, a new grant funds research into payment models that reward results, not just services.

A new class-action lawsuit claims Michigan fails its constitutional duty to Detroit students, igniting a battle over systemic funding and educational rights.

In 2025, a non-profit delivered 53,000 hours of free virtual programs, from pet painting to yoga, creating a new blueprint for aging well.

The energy tech giant completes its EMEA business divestiture to AURELIUS, sharpening focus on the Americas and APAC while reshaping Europe's grid market.

A new clinical trial is underway for a next-gen aortic valve, promising a less invasive procedure and improved durability for millions of patients.

Reykjavík's premier music festival returns with a stellar first wave, promising unique shows from The Streets, Shygirl, and Daði Freyr with an orchestra.

The nation's top farm co-op faces mounting losses from biofuel rules and weak grain markets, signaling wider distress across the American heartland.

Retired NASA astronaut and UMD alumna Dr. Jeanette Epps will inspire the Class of 2026, bringing her story of 'fearless determination' back to campus.

With stellar trial data for its cholesterol drug obicetrapib, NewAmsterdam Pharma faces investors as it navigates a competitive market and awaits key results.

As Spectral AI preps its revolutionary DeepView wound scanner for launch, new CFO David McGuire brings crucial public company expertise to a pivotal transition.

Ovid Therapeutics is spotlighting a novel drug class targeting KCC2, a key brain protein. Could this be the key to treating psychosis and epilepsy?

Asher House Wellness becomes Lillie&Lee, leveraging its founder's viral rescue fame to build a transparent wellness empire for both pets and people.

With a $10k minimum, Heron's new strategy gives investors access to institutional real estate funds amid signs of a potential market recovery.

MCG vertically integrates its supply chain by acquiring TxLa Systems, boosting manufacturing capacity to meet soaring power demands from data centers.

American Public Media's new Inform Media Network consolidates dozens of stations, offering advertisers a brand-safe path to a premium podcast audience.

A major broadband project finishes early, bringing high-speed internet to thousands in underserved areas and future-proofing the state for a digital economy.

TAE Life Sciences' new therapy combines precision radiation with immunotherapy, showing 100% tumor regression in preclinical studies for hard-to-treat cancers.